-+ 0.00%
-+ 0.00%
-+ 0.00%

UPDATE - QUINCE THERAPEUTICS ANNOUNCES CLINICALLY MEANINGFUL IMPROVEMENTS ACROSS FUNCTIONAL, HEMODYNAMIC AND BIOMARKER MEASURES IN PHASE 2 STUDY IN PAH AND PH-ILD

Reuters·05/18/2026 14:21:49

Please log in to view news